ABSTRACT
Protein kinases have an important role in signal transduction in the cellular system via protein phosphorylation. RhoA activated Rho-kinases have a pivotal role in the regulation of smooth muscle contraction. ROCK I and ROCK II phosphorylate myosin-phosphatase and myosin-kinase, which induces contraction in the myometrium. Several studies have investigated the affinity of isoquinoline alkaloids (HA-1077, H1152P) to Rho-kinases, and these compounds notably inhibited the Ca2+-independent process. We measured the efficiency of 25 original, newly synthesized isoquinoline derivatives for the Rho-kinase activity using Rho-associated kinase activity assay and determined their effects on the non-pregnant, 20-day pregnant and parturient rat myometrial contraction in vitro. The IC50 values of 11 from among the 25 derivatives were significantly lower on the oxytocin-induced non-pregnant rat uterine contraction compared with Y-27632 and fasudil, although their maximal inhibitory effects were weaker than those of Y-27632 and fasudil. We measured the effects of 11 isoquinoline molecules with significant IC50 values on ROCK II activity. We found two isoquinolines out of 11 compounds (218 and 852) which decreased the active ROCK II level similarly as Y-27632. Then we found that 218 and 852 relaxed the 20th-day pregnant and parturient rat uterus with greater potency as compared with fasudil. The majority of the synthesized isoquinoline derivatives have uterus relaxant effects and two of them significantly suppress the Rho-kinase mediated myosin light chain phosphorylation. Our results may suggest that the isoquinoline structure has a promising prospect for the development of new and effective inhibitors of uterine contractions in preterm birth.
Subject(s)
Isoquinolines/pharmacology , Protein Kinase Inhibitors/pharmacology , Uterine Contraction/drug effects , rho-Associated Kinases/antagonists & inhibitors , Animals , Dose-Response Relationship, Drug , Female , Isoquinolines/chemical synthesis , Isoquinolines/chemistry , Molecular Structure , Pregnancy , Protein Kinase Inhibitors/chemical synthesis , Protein Kinase Inhibitors/chemistry , Rats , Structure-Activity Relationship , rho-Associated Kinases/metabolismABSTRACT
Activation of RhoA and Rho-associated kinases (ROCKs) is known to play a pivotal role in the regulation of smooth muscle contraction via phosphorylation of myosin-light chain and myosin phosphatase. There are few data on the RhoA and ROCKs expression levels in rat uteri. Therefore, our aim was to investigate the mRNA and protein concentration of RhoA and ROCKs in rat uterus during pregnancy, during parturition and post-partum using real time PCR and Western blot analysis. The other purpose was to evaluate the effects of the ROCK (Y-27632, fasudil and RKI 1441) and RhoA inhibitors (simvastatin) on uterine contractility in isolated organ bath experiments. The mRNA and protein levels of RhoA decreased on the 5th day of pregnancy to day 22, then a sharp increase was detected at term. The mRNA and protein concentration of ROCKs was down-regulated in the early stage of pregnancy, while it sharply increased during parturition. The RhoA-inhibitor simvastatin relaxed the uterus contractions, although its inhibitory effects were not followed by the alteration of RhoA. The strongest inhibitory effect of non-selective ROCK inhibitor fasudil was found on non-pregnant uterus, while it elicited milder relaxation on day 22, during parturition and postpartum day 1. The maximum relaxing effects of Y-27632 and RKI 1441 were altered in a proportional way with the target protein expressions. The RhoA/ROCK signalling pathway might be a potential target for the development of new tocolytic agents; however, high specificity to RhoA, ROCK I or ROCK II seems to be fundamental to the high efficacy of uterine relaxation.
Subject(s)
Uterus/physiology , rho GTP-Binding Proteins/physiology , rho-Associated Kinases/physiology , Animals , Female , Parturition/physiology , Pregnancy , Rats, Sprague-Dawley , Uterine Contraction , Uterus/metabolism , rho GTP-Binding Proteins/genetics , rho GTP-Binding Proteins/metabolism , rho-Associated Kinases/genetics , rho-Associated Kinases/metabolismABSTRACT
ATP-sensitive potassium channels (K(ATP) channels) are composed of sulfonylurea receptors (SURs) and potassium inward rectifiers (Kir(6.x)) that assemble to form a large octameric channel. This study was designed to examine the expression and role of sulfonylurea-binding regulatory subunits 1 (SUR1 (ABCC8)) and 2 (SUR2 (ABCC9)) of the K(ATP) channels in the pregnant rat myometrium with particular regard to the contractility. RT-PCR and western blot analyses were performed to detect the presence of SUR1 and SUR2. The SUR1 levels were markedly increased in the early stages of pregnancy. The highest level was detected on day 6 of pregnancy, whereas in the late stages, the levels of SUR1 were significantly decreased. The SUR2 level remained unchanged throughout pregnancy. The SUR non-selective diazoxide and the SUR2-selective pinacidil inhibited oxytocin-induced contractions. Glibenclamide, a K(ATP) channel blocker, antagonized both pinacidil- and diazoxide-induced relaxations. It was established that SURs are responsible for pharmacological reactivity of K(ATP) channel openers. We conclude that both SURs are involved in the K(ATP) channel in the pregnant rat myometrium. It may further be concluded that 'pinacidil-like' K(ATP) channel openers may be of therapeutic relevance as tocolytic agents in the future.
Subject(s)
KATP Channels/metabolism , Myometrium/metabolism , Pregnancy Proteins/metabolism , Protein Subunits/metabolism , Sulfonylurea Compounds/metabolism , ATP-Binding Cassette Transporters/agonists , ATP-Binding Cassette Transporters/antagonists & inhibitors , ATP-Binding Cassette Transporters/genetics , ATP-Binding Cassette Transporters/metabolism , Animals , Diazoxide/antagonists & inhibitors , Diazoxide/pharmacology , Female , Gene Expression Regulation , In Vitro Techniques , KATP Channels/agonists , KATP Channels/antagonists & inhibitors , KATP Channels/genetics , Myometrium/drug effects , Oxytocin/antagonists & inhibitors , Oxytocin/metabolism , Pinacidil/antagonists & inhibitors , Pinacidil/pharmacology , Potassium Channel Blockers/pharmacology , Potassium Channels, Inwardly Rectifying/agonists , Potassium Channels, Inwardly Rectifying/antagonists & inhibitors , Potassium Channels, Inwardly Rectifying/genetics , Potassium Channels, Inwardly Rectifying/metabolism , Pregnancy , Pregnancy Proteins/agonists , Pregnancy Proteins/antagonists & inhibitors , Pregnancy Proteins/genetics , Protein Isoforms/agonists , Protein Isoforms/antagonists & inhibitors , Protein Isoforms/genetics , Protein Isoforms/metabolism , Protein Subunits/agonists , Protein Subunits/antagonists & inhibitors , Protein Subunits/genetics , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Receptors, Drug/agonists , Receptors, Drug/antagonists & inhibitors , Receptors, Drug/genetics , Receptors, Drug/metabolism , Sulfonylurea Receptors , Tocolytic Agents/pharmacology , Uterine Contraction/drug effectsABSTRACT
The beneficial effects of pregnancy on the symptoms of inflammatory diseases are well documented. The modulation in the uterine functions in the presence of generalized inflammation, however, is much less characterized. The aim of the present study was to explore the modulatory action of adjuvant arthritis on the adrenergic functions of the uterus in nonpregnant and late pregnant rats. Adjuvant arthritis was induced by the subplantar injection of M. butyricum. Presynaptic functions were characterized by a superfusion technique and by registration of the contractions of isolated uterine rings elicited by electric field stimulation. The functions of the adrenoceptors were characterized by constructing concentration-response curves with agonists for both α- and ß-receptors. Where these curves differed significantly from the control, the expressions of these receptors at the mRNA level were additionally determined. Adjuvant arthritis substantially decreased the uptake and release of [(3)H]noradrenaline in myometrial samples from nonpregnant rats, but caused no change at term. The electrically induced contractions were decreased by inflammation in both gestational states. Arthritis resulted in decreased ß-adrenoceptor-mediated relaxation (in both the nonpregnant and the late-pregnant animals) and an increase in α-mediated contraction at term. It can be concluded that adjuvant arthritis deteriorates the adrenergic innervation of the uterus. The effects of exogenous sympathomimetics are shifted, favoring a state of higher contractility. If similar mechanisms are operative in humans, the present results could imply that ß-adrenoceptor agonists are not ideal tocolytics when pregnancy is complicated by generalized inflammation.
Subject(s)
Arthritis, Experimental/physiopathology , Myometrium/innervation , Myometrium/physiology , Pregnancy Complications/physiopathology , Adrenergic Agents/pharmacology , Adrenergic beta-Agonists/pharmacology , Animals , Dose-Response Relationship, Drug , Female , Myometrium/metabolism , Norepinephrine/analysis , Norepinephrine/pharmacology , Pregnancy , Rats , Rats, Sprague-Dawley , Terbutaline/pharmacology , Tocolytic Agents/pharmacology , Uterine Contraction/drug effectsABSTRACT
The actions of the endogenous peptide nociceptin (PNOC; previously abbreviated as N/OFQ) on the myometrium have not been investigated previously. Our aim was to study the presence and functional role of PNOC in the modulation of uterine contractility in pregnant rats at term. The presence of PNOC and its receptors (OPRL1; previously called NOP) in the uterus were detected by radioimmunoassay and radioligand-binding experiments. The PNOC-stimulated G protein activation was assessed by a [(35)S]GTPgammaS-binding technique. The effects of PNOC in uterine rings precontracted with KCl or oxytocin were also tested in vitro. Uterine levels of cAMP were measured by enzyme immunoassay. The K(+) channel blockers tetraethylammonium and paxilline were used to study the role of K(+) channels in mediating the uterine effects of PNOC. Both PNOC and OPRL1 were present in the uterus. PNOC revealed a maximum contraction inhibition of approximately 30%, which was increased to 40% by naloxone. Naloxone and pertussis toxin significantly attenuated the G protein-stimulating effect of PNOC. The uterine cAMP levels were elevated by PNOC and naloxone and after preincubation with pertussis toxin. Tetraethylammonium and paxilline reduced the contraction-inhibiting effect of PNOC and naloxone to approximately 10% and 15%, respectively. We presume that PNOC plays a role in regulating uterine contractility at term. Its effect is mediated partly by stimulatory heterotrimeric G (G(s)) proteins coupled to OPRL1 receptors and elevated cAMP levels, and also by Ca(2+)-dependent K(+) channels. Our results demonstrate a novel action and signaling pathway for PNOC that might be a potential drug target.
Subject(s)
GTP-Binding Protein alpha Subunits, Gs/metabolism , Opioid Peptides/metabolism , Pregnancy/metabolism , Receptors, Opioid/metabolism , Uterine Contraction/metabolism , Uterus/metabolism , Animals , Cyclic AMP/metabolism , Female , Guanosine 5'-O-(3-Thiotriphosphate)/metabolism , In Vitro Techniques , Large-Conductance Calcium-Activated Potassium Channel alpha Subunits/metabolism , Radioligand Assay , Rats , Rats, Sprague-Dawley , Signal Transduction , Sulfur Radioisotopes/metabolism , Nociceptin Receptor , NociceptinABSTRACT
The objective of the study in rats was to investigate the anti-inflammatory effects of pure meloxicam (ME) with different particle sizes and of physical mixtures of the binary ME-mannitol system. The level of local inflammation was significantly decreased when the amount of mannitol was the highest and the particle size of ME was the lowest as well as the components had the interparticulate interaction. The same results were achieved in in vitro experiments.
Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/chemistry , Mannitol/chemistry , Thiazines/chemistry , Thiazoles/chemistry , Animals , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Carrageenan , Chemistry, Pharmaceutical , Dose-Response Relationship, Drug , Inflammation/chemically induced , Inflammation/prevention & control , Male , Mannitol/pharmacology , Meloxicam , Particle Size , Rats , Solubility , Thiazines/pharmacology , Thiazoles/pharmacologyABSTRACT
Pregnancy-induced diabetes mellitus poses one of the greatest challenges in obstetrical practice. The direct action of diabetes on the myometrial adrenergic functions has not been completely characterized. Accordingly, the present study relates to the impact of experimentally induced diabetes on the presynaptic functions of the rat uterus in relation to gestational age. Experiments were carried out on non-pregnant, early-pregnant (day 7), middle-pregnant (day 14) and late-pregnant (day 21) animals. Diabetes was induced with streptozotocin (60 mg/kg, i.v.) in virgin female or early-pregnant animals (on day 2 for the day 7 experiments and on day 5 for the experiments on the middle and late-pregnant animals). Myometrial samples were utilized for superfusion experiments. After saturation, [3H]noradrenaline perfusate fractions were collected and electric field stimulation was applied to determine the amount of transmitter liberated. Additionally, the total uptake capacity of each sample was assayed. Experimental diabetes decreases the transmitter uptake capacity both in virgin rats and at all stages of pregnancy. In early pregnancy (on day 7), this limitation in uptake is obvious as early as 5 days after the induction of diabetes. In non-pregnant animals, the electrically stimulated transmitter release is inhibited substantially, a similar decrease being observed only at mid-pregnancy (day 14). The present superfusion study proves that experimental diabetes depresses the presynaptic adrenergic functions (both the transmitter uptake and the stimulated release) in the myometrium of the rat. Since the effect of diabetes on the uptake capacity can be detected earlier than for generally accepted markers of peripheral neuropathies, superfusion can be suggested as a sensitive and reliable approach for investigations of hyperglycaemia-related functional deteriorations. We speculate that diabetes-induced functional deterioration of the adrenergic nerves could partially explain the anomalies of the reproductive functions found in diabetic patients if a similar mechanism is operative in humans.
Subject(s)
Diabetes Mellitus, Experimental/physiopathology , Sympathetic Nervous System/physiopathology , Uterus/innervation , Uterus/physiology , Animals , Electric Stimulation , Female , Myometrium/metabolism , Norepinephrine/metabolism , Perfusion , Pregnancy , Rats , Rats, Sprague-DawleyABSTRACT
The Publisher regrets that this article is an accidental duplication of an article that has already been published in Neurochemistry International, doi:10.1016/j.neunet.2005.10.001. The duplicate article has therefore been withdrawn.
ABSTRACT
OBJECTIVE: To investigate the effect of the fermented wheat germ extract (Avemar)in patients with severe rheumatoid arthritis (RA). METHODS: Fifteen female RA (Steinbrocker II-III) patients, who had unsuccessfully tried two different DMARD treatments, were enrolled in an open-label, 1-year long, pilot clinical study. DMARD and steroid therapies were recorded and continued. All patients received Avemar as additional therapy. For measurement of efficacy the Ritchie Index, the Health Assessment Questionnaire (HAQ) and the assessment of morning stiffness were applied. Patients were evaluated at baseline, 6 and 12 months. For statistical analyses the Wilcoxon test was used. RESULTS: At both 6 and 12 months, Ritchie index, HAQ and morning stiffness showed significant improvements compared with the baseline values. Dosages of steroids could be reduced in about half of the patients. No side effects of Avemar were observed. CONCLUSION: Supplementation of standard therapies with a continuous administration of Avemar is beneficial for RA patients.
Subject(s)
Arthritis, Rheumatoid/diet therapy , Plant Extracts/administration & dosage , Triticum , Arthritis, Rheumatoid/physiopathology , Dietary Supplements , Female , Health Status , Humans , Joints/drug effects , Joints/physiopathology , Pilot Projects , Severity of Illness Index , Surveys and QuestionnairesABSTRACT
The pregnancy-induced rapid degeneration of the adrenergic nerves innervating the uterus is a well-known but poorly understood phenomenon. Since most of the published investigations were carried out by histological assay, our aim was to describe the loss of the adrenergic function during pregnancy and the re-innervational procedure in the postpartum period. Myometrial and cervical samples from rats were loaded with [3H]noradrenaline and then transferred into a chamber for superfusion. After a wash-out period, fractions were collected. The fifth and fifteenth fraction tissues were stimulated with an electric field. The [3H]noradrenaline contents of the fractions were determined, together with the amount remaining in the tissue. The myometrial [3H]noradrenaline release was substantially decreased in early pregnancy, and absent in the late stage. Differences in release profile were detected between the implantation sites and the interimplantation areas. As a refinement of the results of previous histochemical studies, the noradrenergic functions of the cervix were found to be deeply affected in the early postpartum period. The pregnancy-induced denervational procedure can be followed by means of a superfusional technique after [3H]noradrenaline loading. As our technique is considered to be similar in sensitivity to histological methods, superfusion can be regarded as a model for functional investigations of pregnancy-induced denervation.
Subject(s)
Cervix Uteri/innervation , Denervation , Myometrium/innervation , Postpartum Period , Pregnancy, Animal , Sympathetic Nervous System/physiology , Animals , Electric Stimulation , Female , Models, Animal , Norepinephrine/metabolism , Perfusion , Pregnancy , Rats , Rats, Sprague-DawleyABSTRACT
In view of their good skin tolerability, glyceryl fatty acid esters were used as organogelators, and their effects in the topical penetration of piroxicam (Px) were investigated. The in vivo skin penetration was evaluated by measuring the anti-inflammatory effect in rats, where we found that Px incorporated into glyceryl fatty acid ester organogels exhibited a significantly greater inhibition of oedema than that of the placebo control either when applied locally (p < 0.001), or via transdermal absorption (p < 0.01 and < 0.05, respectively). As the Px concentration was increased, the extent of oedema inhibition rose in accordance with a power law. Comparisons with traditional galenic organogels and a marketed product revealed that the relative biological availability of Px was better from glyceryl fatty acid ester organogels, except when calculated for D1 versus T2 and T3. In order to predict the extent of in vivo skin absorption, we measured the penetration coefficient and the in vitro penetration. In accordance with theory, the extent of in vivo oedema inhibition increased as P(oct/w) increased, and maximum inhibition was observed at logP = 2.0211. However, the in vitro penetration through a synthetic membrane did not correlate with the in vivo results, the reason for which might be the different natures of the model barriers.
Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Piroxicam/administration & dosage , Piroxicam/pharmacokinetics , Skin Absorption , Animals , Biological Availability , Caprylates/administration & dosage , Dose-Response Relationship, Drug , Female , Gels , Glycerides/administration & dosage , Pharmaceutical Vehicles , Piroxicam/pharmacology , Rats , Rats, Sprague-Dawley , Triglycerides/administration & dosageABSTRACT
Iron(II) sulfate-containing lipophilic matrices were developed by a special hot-melt technology (melt solidification in drops), using stearin, white wax and their mixture as conventional bed materials. The special technology resulted in spherical particles which can be filled directly into capsules; these store iron as a depot and ensure a slow and uniform release, whereby the irritation of the gastric mucosa by the iron can be decreased. The rates of dissolution of the iron(II) sulfate from the various lipophilic matrices were different, but fundamentally low. Kinetic calculations demonstrated that the rate of dissolution of the iron(II) sulfate was of approximately zero kinetic order. The results of in vivo experiments on rabbits correlated well with the in vitro data. The plasma curves for the animals treated with the iron(II) sulfate preparations varied with the excipients in the depot products. The properties and ratio of the bed materials influenced the release of the iron(II) sulfate. In all probability, the release of the active agent can be regulated through the use of a melt of stearin and white wax in different ratios. The development products functioned as a sustained-release system and ensured elimination of the irritation of the gastric mucosa. At the same time, the results justified the applicability of the special hot-melt technology in the development of the solid dosage form.
Subject(s)
Iron/pharmacokinetics , Lipids/pharmacokinetics , Sulfates/pharmacokinetics , Technology, Pharmaceutical/methods , Animals , Chemistry, Pharmaceutical , Iron/chemistry , Lipids/chemical synthesis , Particle Size , Rabbits , Sulfates/chemical synthesisABSTRACT
1. Despite great efforts in recent decades, premature birth is still a leading cause of perinatal morbidity and mortality. beta2-Adrenoceptor agonists are frequently used as tocolytics, although their use is rather controversial. Previous animal studies have revealed that blockade of alpha1A-adrenoceptors results in relaxation of the pregnant rat myometrium. 2. The aim of the present study was to investigate the uterus relaxant effect of the beta2-adrenoceptor agonists (terbutaline, ritodrin) applied together with the subtype-selective alpha1A-adrenoceptor antagonists (WB 4101, 5-methylurapidil) in an in vitro rat model. The main objective of the experiments was to clarify whether there was an additive or a potentiating synergism between the two drug classes. 3. Myometrial rings were taken from female, 22-day pregnant (end-term) Sprague-Dawley rats. Electrical field stimulation (EFS) was used to elicit rhythmical contractions. Non-cumulative concentration-response curves were constructed to the beta2-adrenoceptor agonists and the alpha1A-adrenoceptor antagonists alone and to beta2-adrenoceptor agonists co-administered with the alpha1A-adrenoceptor antagonists. 4. Both groups of drugs inhibited EFS-induced contractions in a dose-dependent way. Administering the beta2-adrenoceptor agonists in combination with the alpha1A-adrenoceptor antagonists resulted in a significant decrease in the EC50 and an increase in the maximal contraction inhibiting effect. 5. The potentiating synergism that has been revealed between beta2-adrenoceptor agonists and alpha1A-adrenoceptor antagonists in the uterus relaxant effect may be of great clinical importance because it could improve the efficacy of therapy of preterm delivery.
Subject(s)
Adrenergic alpha-Antagonists/pharmacology , Adrenergic beta-2 Receptor Agonists , Adrenergic beta-Agonists/pharmacology , Tocolytic Agents/pharmacology , Uterus/drug effects , Adrenergic alpha-1 Receptor Antagonists , Animals , Drug Synergism , Female , Muscle Relaxation/drug effects , Muscle Relaxation/physiology , Pregnancy , Rats , Rats, Sprague-Dawley , Receptors, Adrenergic, alpha-1/physiology , Receptors, Adrenergic, beta-2/physiology , Uterus/physiologyABSTRACT
Eight oxytocin (OT) antagonists with general structure Mpa(1)Sar(7)Arg(8), substituted at position 2 with conformationally constrained and bulky amino acids, were synthesized and pharmacologically tested. Binding affinities and selectivities of compounds for OT, and vasopressin receptor subtypes were investigated. In vitro effects of antagonists were evaluated via inhibition of OT-induced contractions of isolated guinea-pig uterus. The abilities of OT antagonists to inhibit spontaneous contractility in 24 h postpartum rat uterus were investigated. These peptides exhibited pseudoirreversible pharmacological properties, and comprise a novel group of OT antagonists for potential clinical use. Their noncompetitive pharmacological nature can be of therapeutic benefit through a sustained effect on myometrium.
Subject(s)
Hormone Antagonists/chemistry , Hormone Antagonists/pharmacology , Oxytocin/antagonists & inhibitors , Receptors, Oxytocin/metabolism , Tocolytic Agents/chemistry , Tocolytic Agents/pharmacology , Animals , Female , Guinea Pigs , Hormone Antagonists/chemical synthesis , Humans , Muscle Contraction/drug effects , Obstetric Labor, Premature/prevention & control , Pregnancy , Protein Conformation , Rats , Rats, Sprague-Dawley , Tocolytic Agents/chemical synthesis , Uterus/metabolismABSTRACT
It is known that cAMP and cGMP, as an "intracellular second messenger system" play a significant role as a signal system, in the mechanism of action of anti-ulcerogenic (cytoprotective) drugs. According to our present, preliminary investigations it seems that during different experimental circumstances the gastric mucosal 3'-5'-cyclic-cytidine-mono-phosphate (cCMP) 3'-5'-cyclic-uridine-monophosphate and (cUMP) levels were changed--similarly to CAMP and cGMP--and these changes might be a possible indicator of a further, most probably secondary, signal- system role.
Subject(s)
Gastric Mucosa/physiology , Intracellular Membranes/physiology , Signal Transduction/physiology , Animals , Cyclic AMP/metabolism , Cyclic CMP/metabolism , Cyclic GMP/metabolism , Dinoprostone/pharmacology , Epoprostenol/pharmacology , Female , Gastric Mucosa/drug effects , Histamine H2 Antagonists/pharmacology , Nucleotides, Cyclic/metabolism , Ranitidine/pharmacology , Rats , Rats, Wistar , Uridine Monophosphate/metabolismABSTRACT
The protective effects of eleven Salvia species native to Europe against enzyme-dependent and enzyme-independent lipid peroxidation were evaluated. The 50% aqueous methanolic extracts of the leaves of all tested plants were found to be more effective than the positive control alpha-tocopherol acid succinate. The extracts of S. candelabrum, S. ringens, S. tomentosa, S. nemorosa, and S. glutinosa displayed considerable concentration-dependent antioxidative effects that were comparable to those of the medicinal and aromatic plant S. officinalis. The concentrations of flavonoids, hydroxycinnamic acids and total phenolic compounds in each extract were quantified with the aim of clarifying the connection between activity and chemical composition.
Subject(s)
Antioxidants/isolation & purification , Cinnamates/isolation & purification , Coumaric Acids/isolation & purification , Flavonoids/isolation & purification , Plant Extracts/isolation & purification , Plant Leaves/chemistry , Plants, Medicinal/chemistry , Vitamin E/analogs & derivatives , Animals , Antioxidants/pharmacology , Brain/drug effects , Brain/enzymology , Cattle , Cinnamates/pharmacology , Coumaric Acids/pharmacology , Depsides , Dose-Response Relationship, Drug , Flavonoids/pharmacology , Lipid Peroxidation/drug effects , Microsomes, Liver/drug effects , Microsomes, Liver/enzymology , Plant Extracts/pharmacology , Rats , Structure-Activity Relationship , Tocopherols , Vitamin E/pharmacology , Rosmarinic AcidABSTRACT
The adrenergic system plays a major role in the regulation of the contractility of the uterus during pregnancy. This study investigated the role of the alpha(1A)-adrenergic receptor (AR) in this regulation. The use of partial phosphorothioate antisense oligodeoxynucleotides (AONs) permitted the sequence-selective inhibition of AR gene expression. AONs were injected together with a cationic liposomal carrier agent into the post partum rat uterus. Incubation for 12 or 24 h with the most effective AON (480-AON) caused a 58.7 or 53.0% inhibition, respectively, of the expression of the alpha(1A)-AR density, whereas incubation for 36 or 48 h resulted in only a 38.8 or 26.7% inhibition, respectively. The decrease of the alpha(1A)-AR density by 480-AON was demonstrated by Western blot analysis and a radioreceptor binding assay on rat uterus preparations 24 h after delivery. The changes in the contractility of the uterus after AON treatment were measured on isolated rat uterine tissue by electric field stimulation. The significant decrease in the ability of the uterus to contract was indicated by the area under the curve method. The electric field studies revealed that the specific alpha(1A)-blockers 5-methylurapidil and WB 4101 inhibited the rhythmic contraction by about 74 and 70% in the control uteri and by 25 and 20% in 480-AON-treated uteri, respectively. The curves for the beta-mimetic (terbutaline) and alpha(1D)-antagonist (BMY7370) inhibitors were unchanged after 480-AON treatment of the uteri. These results suggest the importance of the alpha(1A)-AR in the tocolytic effect exerted by the alpha(1)-antagonist, although high concentrations of antagonists can not exclude the role of alpha(1D)-ARs, too. Additionally, these prove that the knockdown transformation by AONs offers a useful animal model for the investigation of receptors controlling the function of uterine tissue.
Subject(s)
Adrenergic Antagonists/pharmacology , Oligonucleotides, Antisense/pharmacology , Pregnancy, Animal , Receptors, Adrenergic, alpha-1/physiology , Uterine Contraction/physiology , Uterus/physiology , Animals , Blotting, Western , Electric Stimulation , Female , Pregnancy , Radioligand Assay , Rats , Rats, Sprague-Dawley , Receptors, Adrenergic, alpha-1/drug effects , Receptors, Adrenergic, alpha-1/genetics , Uterine Contraction/drug effects , Uterus/drug effectsABSTRACT
The aim of this study was to characterize the ability of late-pregnant (days 15-22) rat uterine tissue rings to contract in response to electric field stimulation in vitro. For this purpose, maximum rhythmic contractions were elicited by optimum choice of the period time and the pulse width, the two main parameters of electric field stimulation. In parallel, the plasma 17beta-estradiol and progesterone levels were determined. It was found that the contractility ratio, i.e. the quotient of the optimum pulse width and the period time, is a good parameter with which to express the contractility. The larger the contractility ratio, the better the ability to contract. Evaluation of the area under the curve did not furnish information relating to the contractility in this method. A very close correlation was observed between the contractility ratio and the quotient of the 17beta-estradiol and progesterone levels on different days, demonstrating that the in vitro ability characterized by the contractility ratio is in keeping with the physiological regularity. There was also a very close correlation between the contractility ratio and the quotient of the alpha1- and beta-adrenergic receptors, suggesting the main role of the numbers of alpha1-receptor in pregnant uterine contractility. It is believed that this is the first in vitro model to give a numerical measure concerning the ontogeny of uterine contractility in late pregnancy.
Subject(s)
Pregnancy, Animal/physiology , Receptors, Adrenergic, alpha-1/physiology , Uterine Contraction , Animals , Calcium/metabolism , Electric Stimulation , Estradiol/blood , Female , In Vitro Techniques , Pregnancy , Progesterone/blood , Rats , Rats, Sprague-Dawley , Receptors, Adrenergic, alpha-1/analysis , Receptors, Adrenergic, beta/analysisABSTRACT
Tests were performed on the influence of polymer coating films on the rates and the extents of in vitro and in vivo liberation of theophylline from pellets. Uncoated and coated pellets were used in the experiments. The coating material was Eudragit L; The film thickness was varied. The in vivo liberation of theophylline was studied in rabbits. The serum level of the released drug measured with a TDX Analyser. No appreciable difference was observed between the uncoated and the coated pellets as concern the maximum release data, but a significant shift was found in t(max) for Eudragit L coated pellets.
Subject(s)
Acrylic Resins , Drug Implants , Theophylline/pharmacokinetics , Animals , Drug Delivery Systems , Polymers , Polymethacrylic Acids , Rabbits , Theophylline/administration & dosage , Theophylline/blood , Theophylline/chemistryABSTRACT
The adrenergic system plays a major role in the regulation of the pregnant uterine contractility. Our aim was to develop an experimental animal model to study the role of the alpha 1A-adrenergic receptor (AR) in uterine motor activity by antisense oligonucleotides (AONs). AONs were injected with DOTAP and pluronic gel into the uterine lumen of post-partum rats 2-3 hours after delivery. The decrease of the alpha 1A-AR density by AON was demonstrated by RT-PCR method, Western blot analysis and radioligand binding assay on rat uterus preparations 24 h after delivery. The changes in the contractility of the uterus were measured on isolated rat uterine tissue by electric field stimulation (EFS). The EFS investigation demonstrated that the effect of the specific alpha 1A-blocker 5-methylurapidil and WB4101 was significantly decreased in the AON-treated rat uterus as compared to the control group but the effect of the beta-mimetic terbutalin and alpha 1D-antagonist BMY7378 was unchanged. Our result suggest that the alpha 1A-ARs play a very important role in the regulation of uterine contractility, and may serve as the basis for a subsequent new group of tocolytics (uterus selective alpha 1-antagonists), which may lead to more selective therapy than currently used beta-mimetics.